UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14C INFORMATION
AMENDMENT #1
Information
Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934
Check
the appropriate box:
| ☒ |
Preliminary
Information Statement |
| |
|
| ☐ |
Confidential,
For Use of the Commission only (as permitted by Rule 14c-5(d)(2)) |
| |
|
| ☐ |
Definitive
Information Statement |
NATURALSHRIMP
INCORPORATED
(Name
of Registrant as Specified in Its Charter)
Payment
of Filing Fee (Check the appropriate box):
| ☒ |
No
Fee Required |
| |
|
| ☐ |
Fee
computed on table below per Exchange Act Rules 14c-5(g) and 0-11. |
| (1) Title of each class of securities to which transaction
applies: |
| |
| |
| (2) Aggregate number of securities to which transaction applies: |
| |
| |
| (3) Per unit price or other underlying value
of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how
it was determined): |
| |
| |
| (4) Proposed maximum aggregate value of transaction: |
| |
| |
| (5) Total fee paid: |
| |
| |
| ☐ Fee paid previously with preliminary
materials: |
| |
| ☐ Check box if any part of the fee is
offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the form or schedule and the date of its filing. |
| |
| (1) Amount previously paid: |
| |
| |
| (2) Form, Schedule or Registration Statement
No.: |
| |
| |
| (3) Filing party: |
| |
| |
| (4) Date filed: |
| |
SCHEDULE
14C
INFORMATION
STATEMENT
AMENDMENT #1
(Pursuant
to Regulation 14C of the Securities Exchange Act of
1934
as amended)
NATURALSHRIMP
INCORPORATED
6443
Las Colinas Blvd.
Irving,
TX 75039
NOTICE
OF STOCKHOLDER ACTION BY WRITTEN CONSENT
WE
ARE NOT ASKING YOU FOR A PROXY AND
YOU
ARE REQUESTED NOT TO SEND US A PROXY
The purpose of this amendment is to include the proposed name change of
the Company from NaturalShrimp Incorporated to BlueFuture Aquatics.
This
Information Statement is furnished by the Board of Directors of NaturalShrimp Incorporated, a Nevada corporation, (the “Company”)
to the holders of record at the close of business on the record date, September 28, 2025 (the “Record Date”), of the
Company’s outstanding common stock, $0.0001 par value per share (the “Common Stock”), pursuant to Rule 14c-2
promulgated under the Securities Exchange Act of 1934, as amended. Except as otherwise indicated by the context, references in this information
statement to “Company,” “we,” “us,” or “our” are references to NaturalShrimp Incorporated.
This
Information Statement is being furnished to such stockholders for the purpose of informing the stockholders that the Board of Directors
and the majority shareholder of the Company have approved the following corporate action:
| ● | Increase
the number of authorized shares of common shares from 1,400,000,000 to 5,000,000,000 shares
(the “Authorized Increase”). |
| | | |
| | ● | Amend
the Company’s Articles of Incorporation to change the Company’s name from “NaturalShrimp
Incorporated” to “BlueFuture Aquatics” (the “Name Change”).
|
The
corporate action was approved by written consent of in lieu of a meeting from the Board of Directors on August 28, 2025 and from the
majority shareholders of approximately 55.13% of the voting stock of the Company on September 28, 2025.
The
Company will, when permissible following the expiration of the appropriate periods mandated by Rule 14c and the provisions of the Nevada
Revised Statutes, file an amendment to our Articles of Incorporation (the “Amendment”) increasing our authorized shares.
The Name Change will become effective upon the filing of a Certificate
of Amendment with the Secretary of State of the State of Nevada. Upon effectiveness, the Company will operate under the name “BlueFuture
Aquatics” and will take appropriate steps to change its trading symbol, if necessary.
The
entire cost of furnishing this Information Statement will be borne by the Company. We will request brokerage houses, nominees, custodians,
fiduciaries and other like parties to forward this Information Statement to the beneficial owners of the Common Stock held of record
by them.
The
Board of Directors has fixed the close of business on September 28, 2025 as the record date for the determination of shareholders who
are entitled to receive this Information Statement. There were 1,277,546,746 shares of Common Stock issued and outstanding on September
28, 2025. We anticipate that this Information Statement will be filed on or about December 23, 2025 to notice all shareholders
of record as of the Record Date.
Only
one Information Statement is being delivered to two or more security holders who share an address unless we have received contrary instruction
from one or more of the security holders. We will promptly deliver upon written or oral request a separate copy of the Information Statement
to a security holder at a shared address to which a single copy of the document was delivered. If you would like to request additional
copies of the Information Statement, or if in the future you would like to receive multiple copies of information or proxy statements,
or annual reports, or, if you are currently receiving multiple copies of these documents and would, in the future, like to receive only
a single copy, please so instruct us by writing to the corporate secretary at the Company’s executive offices at the address specified
above.
DESCRIPTION
OF THE COMPANY’S CAPITAL STOCK
The
following is a description of the material provisions of our capital stock. The following description is intended to be a summary and
does not describe all the provisions of our articles of incorporation or bylaws or Nevada law applicable to us.
General
As
of September 28, 2025, the Company’s authorized capital stock consisted of 1,400,000,000 shares of Common Stock, par value $0.0001
per share, and 200,000,000 authorized shares of Preferred Stock, par value $0.0001 per share. As of September 28, 2025, 1,277,456,746
shares of Common Stock were issued and outstanding, 5,000,000 shares of Series A Preferred Stock were issued and outstanding, 1,571 shares
of Series E Preferred Stock were issued and outstanding, 750,000 shares of Series F Preferred stock were issued and outstanding and 745
shares of Series G Preferred stock were issued and outstanding.
Common
Stock
The
holders of Common Stock are entitled to one vote for each share held. The affirmative vote of a majority of votes cast at a meeting which
commences with a lawful quorum is sufficient for approval of most matters upon which shareholders may or must vote, including the questions
presented for approval or ratification at an annual meeting of shareholders. However, amendment of the articles of incorporation requires
the affirmative vote of a majority of the total voting power for approval. Common shares do not carry cumulative voting rights, and holders
of more than 50% of the Common Stock voting power have the power to elect all directors and, as a practical matter, to control the company.
Holders of Common Stock are not entitled to preemptive rights.
Series
A Preferred Stock
The
Series A Preferred Stock (the “Series A Preferred Stock”) is not entitled to dividends, but carries liquidation rights
upon the dissolution, liquidation or winding up of the Company, whether voluntary or involuntary, at which time the holders of the Series
A Preferred Stock shall receive the sum of $0.001 per share before any payment or distribution shall be made on the Company’s common
stock, or any class ranking junior to the Series A Preferred Stock. The shares of Series A Preferred Stock shall vote together as a single
class with the holders of the Company’s common stock for all matters submitted to the holders of common stock, including the election
of directors, and shall carry voting rights of 60 common shares for every share of Series A Preferred Stock. Any time after the two year
anniversary of the initial issuance date of the Series A Preferred Stock, the Series A Preferred Stock shall be convertible at the written
consent of a majority of the outstanding shares of Series A Preferred Stock, in an amount of shares of common stock equal to 100% of
the then outstanding shares of common stock at the time of such conversion.
Series
E Preferred Stock
On
April 14, 2021, the Board authorized the issuance of 10,000 shares of the Company’s Series E Preferred Stock (the “Series
E Preferred Stock”). The shares of Series E Preferred Stock have a stated value of $1,200 per share and are convertible into
shares of common stock at the election of the holder of the Series E Preferred Stock at any time at a price of $0.35 per share, subject
to adjustment (the “Conversion Price”). The Series E Preferred Stock is convertible into that number of shares of common
stock determined by dividing the Series E Stated Value (plus any and all other amounts which may be owing in connection therewith) by
the Conversion Price, subject to certain beneficial ownership limitations. Each holder of Series E Preferred Stock shall be entitled
to receive, with respect to each share of Series E Preferred Stock then outstanding and held by such holder, dividends at the rate of
twelve percent (12%) per annum, payable quarterly. Each share of Series E Preferred Stock shall be redeemed by the Company on the date
that is no later than one calendar year from the date of its issuance. The Series E Preferred Stock are also redeemable at the Company’s
option, at percentages ranging from 115% to 125% for the first 180 days, based on the passage of time. The holders of Series E Preferred
Stock rank senior to the Common Stock and Common Stock Equivalents (as defined in the Series E Designation) with respect to payment of
dividends and rights upon liquidation and will vote together with the holders of the Common Stock on an as-converted basis, subject to
beneficial ownership limitations, on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders
or by written consent). Based upon a subsequent financing, the holder has the option to exchange (in lieu of conversion), all or some
of the shares of Series E Preferred Stock then held for any securities or units issued in a subsequent financing on a $1.00 for $1.00
basis. In the event of a Fundamental Transaction, the holder has the option to request that the Company or the successor entity shall
purchase the Preferred Stock from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black
Scholes value. Upon any triggering event as set forth in the COD, including a change in control or the Company shall fail to have available
a sufficient number of authorized and unreserved shares of common stock to issue to such holder upon a conversion, each holder shall
have the right, exercisable at the sole option of such holder, to require the Company to redeem all of the Series E Preferred Stock then
held by such holder for a redemption price, in cash, equal to the Triggering Redemption Amount (150% of the Stated Value and all accrued
but unpaid dividends and all liquidated damages, late fees and other costs), and increase the dividend rate on all of the outstanding
Preferred Stock held by such Holder to 18% per annum thereafter. Upon any liquidation, dissolution or winding-up of the Company, the
holders shall be entitled to receive out of the assets of the Company an amount equal to the stated value, plus any accrued and unpaid
dividends and any other fees or liquidated damages then due and owing for each share of Preferred Stock, before any distribution or payment
shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in full such
amounts, then the entire assets to be distributed to the holders shall be ratably distributed among the holders in accordance with the
respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.
Series
F Preferred Stock
On
February 22, 2022, the Board of Directors authorized 750,000 Series F Preferred Stock (the “Series F Preferred Stock”)
and filed the Certificate of Designation with Nevada on February 23, 2022. Each individual holder of Series F Preferred Stock has the
right vote on any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders
of the Company each holder of outstanding shares of Series F Preferred Stock will cast 1,000 common shares votes per each share of Series
F Preferred Stock held by such holder.
Series
G Preferred Stock
On
December 1, 2023, the Board authorized the issuance of 10,000 Series G preferred shares to be designated as Series G Preferred Stock
(the “Series G Preferred Stock”). The Series G Preferred Stock has a par value of $0.0001, a stated value of $1,200 and bear
dividends at the rate of 8% per annum, payable quarterly, to be paid in cash or in-kind, at the discretion of the Company. The Series
G Preferred Stock will vote together with the common stock on an as-converted basis subject to the beneficial ownership limitations.
The Series G Preferred Stock is required to be redeemed by the Company no later than one calendar year from the date of its issuance.
The Series G Preferred Stock is also redeemable at the option of the Company at any time after the original issued date, upon 3 business
days’ notice, at a premium rate which is (a) 1.15 if all of the Series G Preferred Stock is redeemed within 90 calendar days from
the issuance date thereof; (b) 1.2 if all of the Series G Preferred Stock is redeemed after 90 calendar days and within 120 calendar
days from the issuance date thereof; (c) 1.25 if all of the Series G PS is redeemed after 120 calendar days and within 180 calendar days
from the issuance date thereof. The Company shall be permitted to redeem the Series G Preferred Stock at any time in cash upon 3 business
days prior notice to the Holder or the Holder may convert the Series G Preferred Stock within 3 business days period prior to redemption.
The Holder shall have the right to either redeem for cash or convert the Series G Preferred Stock into common stock within 3 business
days following the consummation of a qualified offering. The conversion price is based on the discounted market price which is the lower
of: (i) A fixed price equaling the closing bid price for the common stock on the trading day preceding the execution of the SPA ; or
(ii) 100% of the lowest volume weighted average price (“VWAP)” for the common stock during 10 trading days preceding the
conversion request, subject to adjustment.
Quorum
The
presence, in person or by proxy, of holders of at least a majority of the issued and outstanding shares entitled to vote at a meeting
of stockholders shall constitute a quorum for the transaction of business.
Stock
Transfer Agent
The
stock transfer agent for our securities is TranShare Securities Transfer and Registrar of Clearwater, Florida. Their address is 17755
North US Highway 19, Suite 140, Clearwater, FL 33764. Their phone number is (303) 662-1112. Our Common Stock is quoted under the symbol
“SHMP.”
INTERESTS
OF CERTAIN PERSONS IN OR OPPOSITION TO MATTERS TO BE ACTED UPON
No
director, executive officer, associate of any director or executive officer or any other person has any substantial interest, direct
or indirect, by security holdings or otherwise, in the Authorized Increase which is not shared by all other holders of the shares of
Common Stock
PRINCIPAL
SHAREHOLDERS AND SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The
following sets forth the number of shares of our $0.0001 par value common stock beneficially owned by (i) each person who, as of September
28, 2025, was known by us to own beneficially more than five percent (5%) of our common stock; (ii) our individual Officers and Directors
and (iii) our Officers and Directors as a group. A total of 1,277,546,746 common shares were issued and outstanding as of September 28,
2025.
| | |
Common Stock | | |
% of Common | | |
| | |
% of Voting | |
| | |
Shares | | |
Stock Shares | | |
Voting Shares | | |
Shares | |
| | |
Beneficially | | |
Beneficially | | |
Beneficially | | |
Beneficially | |
| Beneficial Owner | |
Owned | | |
Owned | | |
Owned | | |
Owned (7) | |
| Gerald Easterling | |
| 35,460,945 | (1) | |
| 4.96 | %(3) | |
| 553,456,907 | (4) | |
| 28.78 | % |
| William Delgado | |
| 5,715,719 | (2) | |
| * | | |
| 255,715,719 | (5) | |
| 13.30 | % |
| Tom Untermeyer | |
| 5,140,666 | (2) | |
| * | | |
| 255,140,666 | (6) | |
| 13.27 | % |
| Directors and | |
| | | |
| | | |
| | | |
| | |
| Executive Officers as | |
| | | |
| | | |
| | | |
| | |
| a Group (three | |
| | | |
| | | |
| | | |
| | |
| persons) | |
| | | |
| | | |
| | | |
| | |
| Total | |
| 46,317,330 | | |
| 5.15 | % | |
| 1,064,313,292 | | |
| 55.34 | % |
*
Less than 1%
| (1) |
Consists
of (a) 3,456,907 shares of common stock and (b) 32,004,038 shares of common stock into which the 5 million shares of Series A Preferred
Stock is convertible. |
| |
|
| (2) |
Consists
solely of shares of common stock owned. Of the 5,715,719 shares owned, all but 500,000 are held by Dragon Acquisitions LLC, of which
Mr. Delgado is the managing member. |
| |
|
| (3) |
Solely
with regard to Mr. Easterling, the percentage is based on the 880,401,536 shares of common stock outstanding plus the 32,004,038
shares of common stock into which the 5 million shares of Series A Preferred Stock is convertible. |
| |
|
| (4) |
Consists
of (a) 3,456,907 shares of common stock, (b) 300 million votes to which the 5 million shares of Series A Preferred Stock held by
Mr. Easterling is entitled (60 votes per share), and (c) 250 million votes to which the 250,000 shares of Series F Preferred Stock
held by Mr. Easterling is entitled (1,000 votes per share). |
| |
|
| (5) |
Consists
of (a) 5,715,719 shares of common stock and (b) 250 million votes to which the 250,000 shares of Series F Preferred Stock held by
Mr. Delgado is entitled (1,000 votes per share). |
| |
|
| (6) |
Consists
of (a) 5,140,666 shares of common stock and (b) 250 million votes to which the 250,000 shares of Series F Preferred Stock held by
Mr. Untermeyer is entitled (1,000 votes per share). |
| |
|
| (7) |
Each
percentage in this column is based on (a) 880,401,536 shares of common stock outstanding, (b) 300 million votes to which the 5 million
shares of Series A Preferred Stock outstanding is entitled (60 votes per share), (c) 5,143,000 votes to which the 1,500 shares of
Series E Preferred Stock outstanding is entitled, and (c) 750 million votes to which the 750,000 shares of Series F Preferred Stock
outstanding is entitled (1,000 votes per share). |
DESCRIPTION
OF CONSENT ACTIONS
AMENDMENT
TO THE ARTICLES OF INCORPORATION TO
INCREASE
OF AUTHORIZED SHARES
Our
current Articles of Incorporation state that the number of authorized shares of Common Stock is limited to 900,000,000 shares. As of
September 28, 2025 a total of 1,277,546,746 shares of Common Stock were issued and outstanding. The purpose of the increase in the authorized
Common Stock is to provide our Company’s management with certain abilities including, but not limited to, the issuance of Common
Stock to be used for public or private offerings, conversions of convertible securities, issuance of options pursuant to employee stock
option plans, acquisition transactions and other general corporate purposes.
Our
Board of Directors and majority shareholders approved the Amendment to increase the number of authorized shares of Common Stock to 4,600,000,000
shares and the authorized shares of Preferred Stock to 400,000,000. The par value of the common and preferred shares will not be changed.
The
Amendment for the increase in authorized shares will become effective upon filing of the Amendment promptly following the 10th day after
the mailing of this Information Statement to our stockholders as of the Record Date.
The
form of the Certificate of Amendment to be filed with the Secretary of State of the State of Nevada is set forth as Appendix A
to this Information Statement.
The Board of Directors and the Majority Stockholder have approved an amendment
to Article 1 of the Company’s Articles of Incorporation to change the Company’s name from “NaturalShrimp Incorporated”
to “BlueFuture Aquatics.” The Board believes that the new name better reflects the Company’s evolving strategic direction
and future growth initiatives. The Name Change will not affect the rights of existing stockholders. Outstanding stock certificates representing
shares of common stock will not need to be exchanged. New stock certificates issued after the effective date of the Name Change will bear
the new corporate name. The Name Change will become effective upon the filing of the Certificate of Amendment with the Secretary of State
of the State of Nevada, which is expected to occur promptly following the expiration of the ten (10) day period required under Rule 14c-2.
Distribution
and Costs
We
will pay the cost of preparing, printing and distributing this Information Statement.
Absence
of Dissenters’ Rights of Appraisal
Neither
the adoption by the board of directors nor the approval by the Majority Stockholder of the amendment to our articles of incorporation
provides shareholders any right to dissent and obtain appraisal of or payment for such shareholder’s shares under the Nevada Revised
Statutes, the articles of incorporation or the bylaws.
Potential
Anti-Takeover Effects of Amendment
Release
No. 34-15230 of the staff of the SEC requires disclosure and discussion of the effects of any stockholder proposal that may be used as
an anti-takeover device. The increase in authorized Common Stock may make it more difficult or prevent or deter a third party from acquiring
control of our Company or changing our Board and management, as well as inhibit fluctuations in the market price of our Company’s
shares that could result from actual or rumored takeover attempts. The proposed increased in our authorized Common Stock is not the result
of any such specific effort, rather, as indicated below, the purpose of the increase in the authorized Common Stock is to provide our
Company’s management with certain abilities, and not to construct or enable any anti-takeover defense or mechanism on behalf of
our Company. While it is possible that management could use the additional shares to resist or frustrate a third-party transaction providing
an above-market premium that is favored by a majority of the independent Shareholders, our Company presently has no intent or plan to
employ any additional authorized shares as an anti-takeover device.
Other
than this proposal, our Board of Directors does not currently contemplate the adoption of any other amendments to our Articles of Incorporation
that could be construed to affect the ability of third parties to take over or change the control of the Company.
Our
Articles of Incorporation and Bylaws contain certain provisions that may have anti-takeover effects, making it more difficult for or
preventing a third party from acquiring control of the Company or changing its board of directors and management. According to our Bylaws
and Articles of Incorporation, the holders of the Company’s common stock do not have cumulative voting rights in the election of
our directors. The combination of the present ownership by a few stockholders of a significant portion of the Company’s issued
and outstanding common stock and lack of cumulative voting makes it more difficult for other stockholders to replace the Company’s
board of directors or for a third party to obtain control of the Company by replacing its board of directors.
Potential
Dilution Effects of Amendment
The
increase in our authorized shares could result in dilution to our current shareholders, if the Company issues additional shares of common
stock. Any dilution to our current shareholders would result in less voting power than was held by our current shareholders prior to
any issuance of additional common shares.
INDEBTEDNESS
OF EXECUTIVE OFFICERS AND DIRECTORS
No
executive officer, director or any member of these individuals’ immediate families or any corporation or organization with whom
any of these individuals is an affiliate is or has been indebted to us since the beginning of our last fiscal year.
LEGAL
PROCEEDINGS
As
of the date of this Information Statement, there are no material proceedings against the Company or to which any of our directors, executive
officers, affiliates or stockholders is a party adverse to us.
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTION
Promissory
Note - related parties
On
August 10, 2022, the Company entered into a loan agreement for an aggregate of $430,000 with six related parties, which is to be considered
priority debt of the Company. As of the date of this report, six of the related parties have entered into promissory notes under loan
agreements, for a total of cash received of $430,000. The notes bear interest at 10% per annum and are due one year from the date of
the note. For the year ended March 31, 2025, the interest expense was $41,996.
COMMUNICATIONS
WITH STOCKHOLDERS
Anyone
who has a concern about our conduct, including accounting, internal accounting controls or audit matters, may communicate directly with
W. Steven Walker our General Counsel/Secretary. Such communications may be confidential or anonymous and may be submitted in writing
addressed care of Gerald Easterling, Chief Executive Officer, NaturalShrimp Incorporated, 6443 Las Colinas Blvd., TX 75239. All such
concerns will be forwarded to the appropriate directors for their review and will be simultaneously reviewed and addressed by the proper
executive officers in the same way that other concerns are addressed by us.
WHERE
YOU CAN FIND MORE INFORMATION
We
file annual, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy the periodic reports,
proxy statements and other information we file with the SEC at the SEC’s public reference room maintained at 100 F. Street N.E.,
Room 1580, Washington, D.C. 20549. You can also request copies of those documents, upon payment of a duplicating fee, by writing to the
SEC. Please call the SEC at 1-800-SEC- 0330. The SEC also maintains an Internet site that contains reports, proxy and information statements
and other information regarding issuers that file with the SEC. The site’s Internet address is www.sec.gov. Copies of these documents
may also be obtained by writing to our address provided above.
SIGNATURE
By
Order of the Board of Directors
Dated:
March 2, 2026
| NATURALSHRIMP INCORPORATED |
|
| |
|
|
| By: |
Gerald Easterling |
|
| |
Chief Executive Officer |
|
Appendix
A
CERTIFICATE
OF AMENDMENT
OF
AMENDED ARTICLES OF INCORPORATION
NATURALSHRIMP
INCORPORATED
(Pursuant
to Section 242 of the
General
Corporation Law of the State of Nevada)
NaturalShrimp
Incorporated a corporation organized and existing under the laws of the State of Nevada (the “Corporation”), hereby
certifies as follows:
1.
The name of this corporation is NaturalShrimp Incorporated. The Corporation’s original Articles of Incorporation were filed with
the Secretary of State of the State of Nevada on July 3, 2008 and were amended on April 23, 2010 and October 30, 2018 (as amended, the
“Articles of Incorporation”).
2.
The Board of Directors of the Corporation duly adopted resolutions proposing to amend the Articles of Incorporation, declaring such amendment
to be advisable and in the best interests of the Corporation and its stockholders, and authorizing the appropriate officers of the Corporation
to solicit the consent of the stockholders therefor.
3.
The amendment to the Articles of Incorporation set forth in paragraph 5 of this Certificate of Amendment was duly adopted by the Board
of Directors of the Corporation in accordance with the provisions of Section 242 of the General Corporation Law of the State of Nevada.
4.
The amendment to the Articles of Incorporation set forth in paragraph 5 of this Certificate of Amendment was duly approved by the stockholders
of the Corporation in accordance with the provisions of Sections 228 and 242 of the General Corporation Law of the State of Nevada.
5. Article 1 of the Articles of Incorporation is
hereby amended and restated in its entirety as follows: “1. The name of the Corporation is BlueFuture Aquatics.”
6.
Article 2 of the Articles of Incorporation is hereby amended and restated in its entirety as follows:
“2.
The aggregate number of shares that the Corporation will have authority to issue is Five Billion (5,000,000,000) of which Four Billion
Six Hundred Million (4,600,000,000) shares will be common stock with par value of $0.0001 per share and Four Hundred Million (400,000,000)
shares will be preferred stock, with a par value of $0.0001 per share.
IN
WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by a duly authorized officer of the Corporation
on this 2nd day of March 2026.
| |
NaturalShrimp Incorporated |
| |
|
| |
Gerald Easterling |
| |
CEO |
